182 related articles for article (PubMed ID: 24063750)
1. Ataxin-3 is a multivalent ligand for the parkin Ubl domain.
Bai JJ; Safadi SS; Mercier P; Barber KR; Shaw GS
Biochemistry; 2013 Oct; 52(42):7369-76. PubMed ID: 24063750
[TBL] [Abstract][Full Text] [Related]
2. Impact of altered phosphorylation on loss of function of juvenile Parkinsonism-associated genetic variants of the E3 ligase parkin.
Aguirre JD; Dunkerley KM; Lam R; Rusal M; Shaw GS
J Biol Chem; 2018 Apr; 293(17):6337-6348. PubMed ID: 29530980
[TBL] [Abstract][Full Text] [Related]
3. Ataxin-3 deubiquitination is coupled to Parkin ubiquitination via E2 ubiquitin-conjugating enzyme.
Durcan TM; Kontogiannea M; Bedard N; Wing SS; Fon EA
J Biol Chem; 2012 Jan; 287(1):531-541. PubMed ID: 22081612
[TBL] [Abstract][Full Text] [Related]
4. The Machado-Joseph disease-associated mutant form of ataxin-3 regulates parkin ubiquitination and stability.
Durcan TM; Kontogiannea M; Thorarinsdottir T; Fallon L; Williams AJ; Djarmati A; Fantaneanu T; Paulson HL; Fon EA
Hum Mol Genet; 2011 Jan; 20(1):141-54. PubMed ID: 20940148
[TBL] [Abstract][Full Text] [Related]
5. Structural transformation of the tandem ubiquitin-interacting motifs in ataxin-3 and their cooperative interactions with ubiquitin chains.
Song AX; Zhou CJ; Peng Y; Gao XC; Zhou ZR; Fu QS; Hong J; Lin DH; Hu HY
PLoS One; 2010 Oct; 5(10):e13202. PubMed ID: 20949063
[TBL] [Abstract][Full Text] [Related]
6. Deubiquitinating function of ataxin-3: insights from the solution structure of the Josephin domain.
Mao Y; Senic-Matuglia F; Di Fiore PP; Polo S; Hodsdon ME; De Camilli P
Proc Natl Acad Sci U S A; 2005 Sep; 102(36):12700-5. PubMed ID: 16118278
[TBL] [Abstract][Full Text] [Related]
7. Solution structure of the E3 ligase HOIL-1 Ubl domain.
Beasley SA; Safadi SS; Barber KR; Shaw GS
Protein Sci; 2012 Jul; 21(7):1085-92. PubMed ID: 22517668
[TBL] [Abstract][Full Text] [Related]
8. Ube2w and ataxin-3 coordinately regulate the ubiquitin ligase CHIP.
Scaglione KM; Zavodszky E; Todi SV; Patury S; Xu P; Rodríguez-Lebrón E; Fischer S; Konen J; Djarmati A; Peng J; Gestwicki JE; Paulson HL
Mol Cell; 2011 Aug; 43(4):599-612. PubMed ID: 21855799
[TBL] [Abstract][Full Text] [Related]
9. Defining the role of ubiquitin-interacting motifs in the polyglutamine disease protein, ataxin-3.
Berke SJ; Chai Y; Marrs GL; Wen H; Paulson HL
J Biol Chem; 2005 Sep; 280(36):32026-34. PubMed ID: 16040601
[TBL] [Abstract][Full Text] [Related]
10. Understanding the role of the Josephin domain in the PolyUb binding and cleavage properties of ataxin-3.
Nicastro G; Todi SV; Karaca E; Bonvin AM; Paulson HL; Pastore A
PLoS One; 2010 Aug; 5(8):e12430. PubMed ID: 20865150
[TBL] [Abstract][Full Text] [Related]
11. Differential interaction of the E3 ligase parkin with the proteasomal subunit S5a and the endocytic protein Eps15.
Safadi SS; Shaw GS
J Biol Chem; 2010 Jan; 285(2):1424-34. PubMed ID: 19875440
[TBL] [Abstract][Full Text] [Related]
12. Mode of substrate recognition by the Josephin domain of ataxin-3, which has an endo-type deubiquitinase activity.
Satoh T; Sumiyoshi A; Yagi-Utsumi M; Sakata E; Sasakawa H; Kurimoto E; Yamaguchi Y; Li W; Joazeiro CA; Hirokawa T; Kato K
FEBS Lett; 2014 Nov; 588(23):4422-30. PubMed ID: 25448680
[TBL] [Abstract][Full Text] [Related]
13. Crystal structure of a Josephin-ubiquitin complex: evolutionary restraints on ataxin-3 deubiquitinating activity.
Weeks SD; Grasty KC; Hernandez-Cuebas L; Loll PJ
J Biol Chem; 2011 Feb; 286(6):4555-65. PubMed ID: 21118805
[TBL] [Abstract][Full Text] [Related]
14. Co-chaperone HSJ1a dually regulates the proteasomal degradation of ataxin-3.
Gao XC; Zhou CJ; Zhou ZR; Zhang YH; Zheng XM; Song AX; Hu HY
PLoS One; 2011; 6(5):e19763. PubMed ID: 21625540
[TBL] [Abstract][Full Text] [Related]
15. Josephin domain of ataxin-3 contains two distinct ubiquitin-binding sites.
Nicastro G; Masino L; Esposito V; Menon RP; De Simone A; Fraternali F; Pastore A
Biopolymers; 2009 Dec; 91(12):1203-14. PubMed ID: 19382171
[TBL] [Abstract][Full Text] [Related]
16. Interaction between RING1 (R1) and the Ubiquitin-like (UBL) Domains Is Critical for the Regulation of Parkin Activity.
Ham SJ; Lee SY; Song S; Chung JR; Choi S; Chung J
J Biol Chem; 2016 Jan; 291(4):1803-1816. PubMed ID: 26631732
[TBL] [Abstract][Full Text] [Related]
17. Functional interactions as a survival strategy against abnormal aggregation.
Masino L; Nicastro G; Calder L; Vendruscolo M; Pastore A
FASEB J; 2011 Jan; 25(1):45-54. PubMed ID: 20810784
[TBL] [Abstract][Full Text] [Related]
18. Structural and functional analysis of ataxin-2 and ataxin-3.
Albrecht M; Golatta M; Wüllner U; Lengauer T
Eur J Biochem; 2004 Aug; 271(15):3155-70. PubMed ID: 15265035
[TBL] [Abstract][Full Text] [Related]
19. The deubiquitinating enzyme ataxin-3, a polyglutamine disease protein, edits Lys63 linkages in mixed linkage ubiquitin chains.
Winborn BJ; Travis SM; Todi SV; Scaglione KM; Xu P; Williams AJ; Cohen RE; Peng J; Paulson HL
J Biol Chem; 2008 Sep; 283(39):26436-43. PubMed ID: 18599482
[TBL] [Abstract][Full Text] [Related]
20. The effects of the polyglutamine repeat protein ataxin-1 on the UbL-UBA protein A1Up.
Riley BE; Xu Y; Zoghbi HY; Orr HT
J Biol Chem; 2004 Oct; 279(40):42290-301. PubMed ID: 15280365
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
